Abbott Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
Abbott Laboratories has a total shareholder equity of $39.6B and total debt of $14.8B, which brings its debt-to-equity ratio to 37.5%. Its total assets and total liabilities are $73.0B and $33.5B respectively. Abbott Laboratories's EBIT is $7.3B making its interest coverage ratio 28.4. It has cash and short-term investments of $7.2B.
Key information
37.5%
Debt to equity ratio
US$14.85b
Debt
| Interest coverage ratio | 28.4x |
| Cash | US$7.22b |
| Equity | US$39.56b |
| Total liabilities | US$33.46b |
| Total assets | US$73.02b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ABT's short term assets ($23.1B) exceed its short term liabilities ($13.8B).
Long Term Liabilities: ABT's short term assets ($23.1B) exceed its long term liabilities ($19.7B).
Debt to Equity History and Analysis
Debt Level: ABT's net debt to equity ratio (19.3%) is considered satisfactory.
Reducing Debt: ABT's debt to equity ratio has reduced from 60.2% to 37.5% over the past 5 years.
Debt Coverage: ABT's debt is well covered by operating cash flow (53.2%).
Interest Coverage: ABT's interest payments on its debt are well covered by EBIT (28.4x coverage).